[Vilon effect on consequences of repeated radioactive and mercuric impact in small doses].
Ivanov. S D SD; Khavinson. V Kh VKh; Malinin. V V VV; Kovan'ko. E G EG; Iamshanov. V A VA; Kondrat'eva. A V AV; Morozov. V G VG
Key Findings
- Repeated low‑dose radiation and mercury caused a drop in lymphocytes (a type of white blood cell) in rats.
- Vilon treatment restored lymphocyte numbers by day 30 and increased granulocyte counts compared to untreated rats.
- Rats given vilon showed lower long‑term mortality over 15 months after the toxic exposures.
Practical Outcomes
- The results suggest vilon might have immune‑supporting effects in stressful or toxic situations, but because the work is limited to rats and involves unusual exposures, it doesn’t provide a clear, safe protocol for human use yet. Biohackers should view this as early, exploratory data rather than a ready‑to‑apply supplement regimen.
Summary
In rats that were repeatedly exposed to low doses of radiation and mercury, a peptide called vilon helped bring white blood cell counts back to normal and seemed to lower death rates over the next year, but the study was done only in animals under toxic conditions, not in healthy people.
Abstract
The purpose of the study was to determine the efficacy of vilon administration in rats after reiterated exposure to ecotoxicants (mercury in concentration near to maximum allowable one and gamma-radiation in small dose). In 24 hours after repeated radioactive and mercuric impact (RMI) and for 30 consecutive days the animals reported lymphopenia. At the same time the indices of DNA leucocytes content and structure did not differ from the parameters of intact animals, this could evidence the development of adaptation reactions. Vilon administration led to the normalization of the lymphocytes number by the 30th day after repeated irradiation (contrary to the radioactive- chemical control), while the number of granulocytes in the test group was higher than that in the intact control group. Study of the survival rate in rats revealed that Vilon reduced morbidity of rats in the course of 15 months after RMI.
Study Information
pubmed
2005